CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop GLIX1, a new drug family that is highly effective against glioblastoma multiforme (GBM), a deadly brain cancer. The goal is to optimize the chemical synthesis of GLIX1 and prepare it for clinical trials.
Survival rates are increasing for most cancers but remain dismal for brain tumours in adults and children.
Gliomas constitute 60% of all brain tumours and 50% of these are considered aggressive malignant tumours.
Among aggressive gliomas, glioblastoma multiforme (GBM) is the deadliest and remains largely incurable.
Our goal is to develop the first GBM drug for both adults and children, to improve its «universally miserable outcomes».
We have discovered a novel family of compounds that are cytoto…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
